Centricity Vision announced new ZEPTOLink enhancements, reducing treatment time by up to 60%. These updates, aimed at ...

PharmAbcine, Inc. (KOSDAQ: 208340), a clinical-stage public company developing next-generation therapeutics to address unmet medical needs, ...

Researchers have identified that the protein CLEC14A disrupts the maturation of bone cells, delaying bone formation. The ...

Researchers have discovered a protein that inhibits the activity of bone-forming cells (osteoblasts) by preventing their ...